Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs)

Health care processes are under constant development and will need to embrace advances in technology and health science aiming to provide optimal care. Considering the perspective of increasing treatment options for people with rheumatic and musculoskeletal diseases, but in many cases not reaching a...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic Advances in Musculoskeletal Disease 2022, Vol.14, p.1759720X221105978-1759720X221105978
Main Authors: De Cock, Diederik, Myasoedova, Elena, Aletaha, Daniel, Studenic, Paul
Format: Article
Language:English
Subjects:
A Glance into the Future of Rheumatology
Medical diagnosis
Medicin och hälsovetenskap
Musculoskeletal diseases
Precision medicine
Rheumatic diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Health care processes are under constant development and will need to embrace advances in technology and health science aiming to provide optimal care. Considering the perspective of increasing treatment options for people with rheumatic and musculoskeletal diseases, but in many cases not reaching all treatment targets that matter to patients, care systems bare potential to improve on a holistic level. This review provides an overview of systems and technologies under evaluation over the past years that show potential to impact diagnosis and treatment of rheumatic diseases in about 10 years from now. We summarize initiatives and studies from the field of electronic health records, biobanking, remote monitoring, and artificial intelligence. The combination and implementation of these opportunities in daily clinical care will be key for a new era in care of our patients. This aims to inform rheumatologists and healthcare providers concerned with chronic inflammatory musculoskeletal conditions about current important and promising developments in science that might substantially impact the management processes of rheumatic diseases in the 2030s.
ISSN:1759-720X
1759-7218
DOI:10.1177/1759720X221105978